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ABSTRACT The SCF ubiquitin ligase complex of budding
yeast triggers DNA replication by catalyzing ubiquitination of the
S phase cyclin-dependent kinase inhibitor SIC1. SCF is com-
posed of three proteins—ySKP1, CDC53 (Cullin), and the F-box
protein CDC4—that are conserved from yeast to humans. As
part of an effort to identify components and substrates of a
putative human SCF complex, we isolated hSKP1 in a two-hybrid
screen with hCUL1, the closest human homologue of CDC53.
Here, we show that hCUL1 associates with hSKP1 in vivo and
directly interacts with both hSKP1 and the human F-box protein
SKP2 in vitro, forming an SCF-like particle. Moreover, hCUL1
complements the growth defect of yeast cdc53ts mutants, asso-
ciates with ubiquitination-promoting activity in human cell
extracts, and can assemble into functional, chimeric ubiquitin
ligase complexes with yeast SCF components. Taken together,
these data suggest that hCUL1 functions as part of an SCF
ubiquitin ligase complex in human cells. Further application of
biochemical assays similar to those described here can now be
used to identify regulatorsycomponents of hCUL1-based SCF
complexes, to determine whether the hCUL2–hCUL5 proteins
also are components of ubiquitin ligase complexes in human
cells, and to screen for chemical compounds that modulate the
activities of the hSKP1 and hCUL1 proteins.
The irreversible nature of proteolysis makes it well suited to serve
as a regulatory switch for controlling unidirectional processes.
This principle is clearly evident in the organization of the cell
division cycle, where initiation of DNA replication, chromosome
segregation, and exit from mitosis are triggered by the destruction
of key regulatory proteins (1–3).
Proteins typically are marked for proteolytic degradation by
attachment of multiubiquitin chains. This process is initiated by
a ubiquitin-activating enzyme (E1), which activates ubiquitin by
adenylation and becomes linked to it via a thiolester bond.
Ubiquitin then is transferred to a ubiquitin-conjugating enzyme,
E2. Whereas E2s can attach ubiquitin directly to lysine residues
in a substrate, most physiological ubiquitination reactions prob-
ably require a ubiquitin ligase, or E3 (4). E3s have been impli-
cated in substrate recognition and, in one case, transfer of
ubiquitin from E2 to a substrate via an E3–ubiquitin-thiolester
intermediate (5). Once the substrate is multiubiquitinated, it then
is recognized and degraded by the 26S proteasome.
A ubiquitination pathway recently has been discovered in
budding yeast (1, 6, 7). Components of this pathway include the
CDC53, CDC4, and ySKP1 gene products, which assemble into
a ubiquitin ligase complex known as SCFCDC4 (for SKP1, Cullin,
F-box protein CDC4); because several of the yeast and human
subunits have identical names—e.g., SKP1—we distinguish them
with the letters y or h, respectively. SCFCDC4 collaborates with the
E2 enzyme yCDC34 to catalyze ubiquitination of the cyclin-
dependent kinase (CDK) inhibitor SIC1. The specificity of
SCFCDC4 is thought to be governed by ySKP1 and the F-box-
containing subunit CDC4, which together form a substrate
receptor that tethers SIC1 to the complex. The assembly of this
receptor is thought to be mediated by a direct interaction between
ySKP1 and the F-box domain of CDC4 (6, 7).
Whereas genetic analysis has revealed that SIC1 proteolysis
requires CDC4, G1 cyclin proteolysis appears to depend on a
distinct F-box-containing protein known as GRR1 (8). Alterna-
tive SCF complexes (SCFGRR1) assembled with GRR1 instead of
CDC4 bind G1 cyclins but not SIC1, suggesting that there exist
multiple SCF complexes in yeast whose substrate specificities are
dictated by the identity of the F-box subunit (7).
Components of the SCF ubiquitination pathway have been
highly conserved during evolution. Human homologues of
yCDC34 and ySKP1 have been reported (9, 10), and F-box-
containing proteins like CDC4 and GRR1 have been identified
in many eukaryotes (11). Many of these F-box proteins also
contain either WD-40 repeats (such as CDC4) or leucine-rich
repeats (such as GRR1). A potential human counterpart of
GRR1, SKP2, has been identified along with hSKP1 as a Cyclin
AyCDK2-associated protein that is necessary for S-phase pro-
gression (10). Homologues of CDC53, which are known as
Cullins, also are present in many eukaryotes, including humans
and nematodes (12, 13).
Studies in budding yeast suggest that SCF substrates must be
phosphorylated before they can be ubiquitinated (14, 15). Several
human cell cycle regulators are targeted for ubiquitination after
their phosphorylation by CDKs, implicating them as potential
substrates of an SCF pathway(s) in human cells. Among them is
the CDK inhibitor p27, the abundance of which may be regulated
by CDC34-dependent ubiquitination (16, 17). In addition, Cyclins
E and D1 are degraded by a ubiquitin-dependent pathway after
phosphorylation at a specific site (18–20). The observation that
Cyclin AyCDK2 associates preferentially with hSKP1 and SKP2
in transformed cells to the exclusion of a proliferating cell nuclear
antigen and p21 (10) raises the possibility that Cyclin A is also a
target of an SCF pathway. Alternatively, SCF-bound Cyclin
AyCDK2 may phosphorylate SCF subunits or potential sub-
strates such as E2F-1yDP-1, thereby activating SCF-dependent
ubiquitination (21, 22).
Despite the conservation of SCF components from yeast to
humans, several observations raise the question of whether the
metazoan homologues are actually components of SCF-like
ubiquitin ligases. First, whereas Saccharomyces cerevisiae cdc53ts
mutants arrest at the G1yS transition, Caenorhabditis elegans cul-1
mutants fail to exit the cell cycle, resulting in hyperplasia of most
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larval tissues (12). It is unclear whether this discrepancy arises
because cul-1 and CDC53 have different functions or because
they are components of distinct ubiquitin ligase complexes with
different substrate specificities. Second, the recent discovery of
ubiquitin-like proteins (RUB1yNEDD8 and SMT3ySUMO1)
that are conjugated to proteins by pathways that involve E1 and
E2 homologs (23) suggests that some homologs of SCF compo-
nents might function in these alternative pathways. Indeed,
attachment of RUB1 to CDC53 fails to occur in skp1 mutants,
suggesting that ySKP1 may be involved directly in the ‘‘rubiny-
lation’’ of CDC53 (24). Third, the best characterized human
Cullin, CUL2, assembles with the von Hippel–Lindau tumor
suppressor proteinyElongin ByElongin C complex that has been
suggested to regulate mRNA transcript elongation and accumu-
lation of hypoxia-inducible mRNAs (25, 26). Fourth, ySKP1 is a
subunit of the centromere-binding CBF3 complex, suggesting
that vertebrate SCF subunits may serve as components of a
variety of unrelated molecular machines (34).
To address whether SCF-like activities are present in animal
cells, we sought hCUL1 binding partners, and we tested whether
putative human SCF subunits can assemble together to yield
complexes with ubiquitin ligase activity. We report here that
hCUL1 is a direct functional homologue of CDC53 because it can
suppress the temperature-sensitive growth of cdc53 mutants, can
associate with ubiquitin-conjugation activity in human cell lysates,
and can substitute for CDC53 in the reconstitution of SIC1
ubiquitination with purified components. Moreover, hCUL1
directly binds to the putative SCF subunits hSKP1 and SKP2.
Taken together, these data provide strong evidence that an
SCF-dependent ubiquitination pathway is conserved from yeast
to mammals.
MATERIALS AND METHODS
Yeast Strains and Reagents. Yeast strains, plasmids, and a
HeLa cDNA library for the two-hybrid screen were a generous
gift from R. Brent (Massachusetts General Hospital). Wx131.2c
cdc53–2ts strain was obtained from M. Goebl (Indiana Univer-
sity). Baculoviruses expressing hCDK2HA, hCyclin A (D. Mor-
gan, University of California, San Francisco), SKP2 (H. Zhang,
Yale University), hSKP1 (P. Sorger, Massachusetts Institute of
Technology) and plasmids pGEX-KG-hSKP1 and pGEX-KG-
SKP2 (P. Jackson, Stanford University) and pCS21nbgal and
pCS21HA-SMC1 (S. Handeli, Fred Hutchinson Cancer Re-
search Center) were kindly provided by the indicated investiga-
tors. Other baculoviruses have been described (6). Ubiquitin and
the Protein Biotinylation Kit were purchased from Sigma, and
biotinylated ubiquitin (BUb) was prepared according to the
manufacturer’s instructions. Ubiquitin aldehyde was a generous
gift from R. Cohen (University of Iowa).
Plasmid and Baculovirus Construction. Full-length hCUL1
ORF was assembled from expressed sequence tags HE2AB96
and HSVAD74 and subcloned into pRS316 and pMALc (New
England Biolabs). The same hCUL1 fragment also was subcloned
into pVL1393 (PharMingen) to generate a hCUL1-expressing
baculovirus. An N-terminal epitope-tagged version of hCUL1
was constructed by inserting a DNA cassette that contains two
tandem repeats of the Polyoma epitope (MEYMPME) followed
by six histidine residues (designated as PHis6) into pRS316-
hCUL1. PHis6hCUL1 fragment then was subcloned into pFAST-
BAC1 (GIBCOyBRL) to generate a PHis6hCUL1 baculovirus and
was subcloned into pDNA3.1yZeo (Invitrogen) to generate
pcDNA3.1-PHis6-hCUL1. pCS21HA-hSKP1 was generated by
subcloning a hSKP1 fragment from pGEX-KG-hSKP1 into
pCS21HA-SMC1.
Antibodies. Anti-hCUL1 antibodies were generated in rabbits
immunized with either a fusion protein containing the first 41
residues of hCUL1 followed by glutathione S-transferase (GST)
(Babco, Richmond, CA) or a fusion protein containing GST
followed by the last 86 residues of hCUL1 (California Institute of
Technology antibody facility). Antibodies against hCUL1 and
GST were affinity purified by using maltose binding protein
(MBP) fusions of the corresponding peptides and GST, respec-
tively, as described (27). Monoclonal anti-Polyoma antibodies
were bound to protein A-Sepharose beads and crosslinked to
protein A with dimethylpimilimadate (27) at a concentration of
'2 mg of antibodies per ml of protein A resin. Anti-HA resin was
generated by coupling 1 ml of anti-HA ascites to 1 ml of CNBr
activated agarose (Pharmacia) according to the manufacturer’s
protocol.
Expression and Purification of Proteins. Proteins expressed in
bacteria or yeast were purified according to standard protocols
and as described (6). For the expression and purification of
chimeric SCF complexes, Hi5 insect cells were infected with
baculoviruses expressing PHACDC4 (PHA designates an epitope-
tag consisting of two tandem repeats of the Polyoma epitope
followed by three hemagglutinin epitopes), CDC53PHA,
PHis6hCUL1 (multiplicities of infection of 6), ySKP1His6, or hSKP1
(multiplicities of infection of 4). Cells were collected 72 hr
post-infection, and lysates were prepared as described (6). The
Polyoma tagged proteins were affinity purified from these lysates
(6) to yield the various SCF complexes.
Cell Cultures and Transfections. WI-38 human lung fibroblasts
were purchased from ATCC. HeLa S3 cells were a gift from S.
Handeli. Cells were grown in DMEM-F12 (GIBCOyBRL) sup-
plemented with 10% fetal bovine serum (GIBCOyBRL) at
37°Cy5%CO2. Cells were transfected in 100-mm dishes by the
modified calcium phosphate method (28). 10 mg pCS21HA-
hSKP1 and 7.5 mg pcDNA3.1-PHis6-hCUL1 vectors were used
per transfection plate. Transfection efficiency was monitored by
cotransfection of 2.5 mg pCS21nbgal plasmid per transfection
plate followed by standard colorimetric bgal assays (29). Total
DNA concentration was 20 mgy100-mm dish and was adjusted for
every transfection plate by adding empty vectors. Cells were
harvested and lysed 24 hr post-transfection.
Immunoprecipitations and Western Blotting. Baculovirus-
infected insect cells were harvested and lysed at 48 hr (for Sf9
cells) or 72 hr (for Hi5 cells) post-infection in 0.8 ml of lysis buffer
per 100-mm plate (as described in ref. 6). Metabolic labeling was
done by incubating insect cells for 3 hr in methionine-deficient
medium plus 20 mCiyml of Tran[35S]-label before lysis. WI-38 and
HeLa S3 cells were lysed in 0.4 ml of lysis buffer per 100-mm
plate. Lysates were cleared by centrifugation at 14,000 3 g for 15
min, were adjusted to 10% glycerol, were frozen in liquid nitro-
gen, and were stored at 280°C. Cell lysates (1 mg) were incubated
with 50 ml of antibody-coupled beads (1:1 suspension in lysis
buffer) for 2 hr at 4°C. Precipitates were washed five times with
1 ml of lysis buffer and were analyzed by SDSyPAGE followed by
Western blotting or autoradiography. Western blotting was per-
formed as described (27). PHis6hCUL1 and HAhSKP1 were de-
tected by rabbit polyclonal anti-hCUL1 and biotinylated anti-HA
(12CA5) primary antibodies and were visualized by incubation
with goat anti-rabbit-horseradish peroxidase (HRP) and strepta-
vidin-HRP conjugates followed by ECL detection (Amersham).
Ubiquitination Reactions. Crude Sf9 cell lysates (500 mg)
prepared from cells infected with Phis6hCUL1 baculovirus were
incubated with 20 ml anti-Polyoma beads for 2 hr at 4°C to allow
Phis6hCUL1 binding. Beads were washed three times with lysis
buffer and were incubated with 1 mg of crude HeLa S3 lysate
overnight at 4°C. Beads then were washed three times with lysis
buffer and were supplemented with 6 mg BUb, 500 ng hCDC34,
25 ng His6yUBA1, 1 ml of 103 ATP-regenerating system (6), 1 ml
of 103 reaction buffer (6), and 0.5 mM ubiquitin aldehyde.
Reactions were adjusted to 10 ml by adding 20 mM Hepes (pH
7.6), 100 mM potassium acetate, 1 mM DTT, were incubated for
90 min at 30°C, and were terminated by adding Laemmli sample
buffer. Samples were analyzed by Western blotting with strepta-
vidin–HRP conjugate. All ubiquitination reactions with chimeric
SCF complexes were performed as described (6).
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RESULTS
Human CUL1-Interacting Proteins. To identify human pro-
teins that interact with hCUL1, we performed a two-hybrid
screen (30, 31). A full-length hCUL1 cDNA, fused to the LexA
DNA-binding domain, was used as a bait to identify cDNAs from
a HeLa library that encode hCUL1 interactors. This screen
yielded clones encoding hSKP1, protein phosphatase 2A catalytic
subunit, and the 20S proteasome subunit HsN3. None of these
clones interacted with LexA-hCDK2 or LexA-Lamin C baits,
suggesting that their interaction with LexA-hCUL1 was specific.
Here, we examine in detail the interaction of hCUL1 with hSKP1
(see below). The physiological significance of the interaction of
hCUL1 with HsN3 or protein phosphatase 2A has not been
evaluated yet.
Human CUL1 Interacts with hSKP1 in Vivo. The identification
of hSKP1 as a hCUL1-interacting protein suggested that these
proteins may be subunits of a complex in human cells that is
similar to the SCF ubiquitin ligase of budding yeast. To test
whether hCUL1 interacts with hSKP1 in vivo, we prepared
affinity-purified rabbit polyclonal antibodies directed against the
N and C termini of hCUL1. Fig. 1A shows specificity of the
affinity-purified antibodies. Both antibodies recognized one ma-
jor polypeptide of '80 kDa in transformed (HeLa S3) and
nontransformed (WI-38) cell lines (Fig. 1A, lanes 1, 2, 6, and 7).
This species comigrated with hCUL1 produced in Hi5 cells
infected with a baculovirus that contains full length hCUL1
cDNA (Fig. 1A, lanes 3 and 8). A more rapidly migrating species
of recombinant hCUL1 detected in Hi5 cells by the anti-C-
terminal antibodies (Fig. 1A, lane 3) presumably represents a
breakdown product or initiation of translation downstream of the
normal start codon because this species was not detected by the
anti-N-terminal antibodies. As expected, addition of a Polyoma
antigen-hexahistidine tag to hCUL1 (PHis6hCUL1) yielded a more
slowly migrating hCUL1 band (Fig. 1A, lanes 4 and 9).
Neither polyclonal antibody precipitated hCUL1 from crude
human cell lysates, precluding analysis of hCUL1 complexes in
nontransfected cells. Thus, to evaluate the potential interaction of
hCUL1 with hSKP1 in vivo, we transfected HeLa S3 cells with
PHis6hCUL1 and HAhSKP1 expression vectors. Lysates were pre-
pared from these cells 24 hr post-transfection and were immu-
noprecipitated by using crosslinked anti-Polyoma or anti-HA
antibody beads. Proteins bound to the beads were separated by
SDSyPAGE and were analyzed by immunoblotting with anti-
hCUL1 and anti-HA antibodies (Fig. 1B). Consistent with the
two-hybrid data, hCUL1 was detected specifically in hSKP1
immunoprecipitates and vice versa.
Human CUL1, hSKP1, and SKP2 Assemble into an SCF-like
Complex that Can Associate with Cyclin AyCDK2 Kinase. Hu-
man SKP1 was initially identified as a Cyclin AyCDK2-associated
protein in transformed human cells (10). This association is
mediated by SKP2, a human F-box protein with leucine-rich
repeats, reminiscent of the GRR1 protein. CDC53 and ySKP1,
together with the F-box protein GRR1, constitute a putative
SCFGRR1 ubiquitin ligase complex that targets G1 cyclins for
degradation (6, 7). The homology of hSKP1, SKP2, and hCUL1
proteins with components of the ySCF complex suggests that the
human proteins may form a similar complex. We addressed this
possibility by immunoprecipitating PHis6hCUL1 from [35S]-
labeled insect cells infected with baculoviruses that express
PHis6hCUL1, hSKP1, and SKP2 (Fig. 2A) and by testing whether
hCUL1 can assemble with a previously described complex con-
taining Cyclin AyCDK2, hSKP1, and SKP2 (Fig. 2B). The
interaction of hCUL1 with the Cyclin AyCDK2HAyhSKP1ySKP2
complex was monitored by immunoprecipitating CDK2HA from
[35S]-labeled insect cells infected with all five viruses in various
combinations. As shown in Fig. 2A, PHis6hCUL1 efficiently as-
sembled with hSKP1 and SKP2, suggesting that these proteins
form a ternary complex similar to ySCF. Surprisingly, hCUL1
interacted with Cyclin AyCDK2HA complexes in the absence of
SKP2 or hSKP1 (Fig. 2B, lane 6; note that hSKP1 does not
associate with Cyclin AyCDK2HA complex in the absence of
SKP2). This interaction may be caused by either a direct inter-
action between hCUL1 and Cyclin AyCDK2HA or the presence
of a bridging protein in insect cells (e.g., see ref. 6). Regardless,
the ability of hCUL1 expressed in insect cells to assemble into
complexes containing a cyclin-dependent kinase is likely to be
physiologically significant because PHis6hCUL1 immunoprecipi-
tates prepared from HeLa S3 cells contained histone H1 kinase
activity (data not shown).
FIG. 1. hCUL1 and hSKP1 interact in vivo. (A) hCUL1 detection by affinity-purified anti-hCUL1 antibodies. Crude human cell lysates (50 mg)
(lanes 1, 2, 6, and 7) and 0.5 mg of crude lysates from Hi5 insect cells, uninfected (lanes 5 and 10) or infected with hCUL1 (lanes 3 and 8) or
PHis6hCUL1 (lanes 4 and 9) viruses, were resolved on an 8% SDS-polyacrylamide gel, transferred to a PVDF membrane, and probed with
anti-hCUL1 antibodies. D4, serum raised against C-terminal part of hCUL1; N1, serum raised against N-terminal part of hCUL1. Asterisk designates
putative N-terminally truncated hCUL1 that is recognized by C-terminal antibody. (B) HeLa S3 cells were transfected with pcDNA3.1-PHis6-
hCUL1 (lanes 1, 4, and 7), pCS21HA-hSKP1 (lanes 3, 6, and 9), or both plasmids (lanes 2, 5, and 8). Lysates (1 mg) were prepared 24 hr
post-transfection and were immunoprecipitated with anti-Polyoma (lanes 4–6) or anti-HA (lanes 7–9) beads. Proteins retained on the beads were
analyzed by Western blotting. Lanes 1–3 contained 20 mg of crude lysates.
FIG. 2. Human CUL1 can interact with human SKP1, SKP2, and
Cyclin AyCDK2. Sf9 insect cells were infected with baculovirus
constructs that express various human proteins as indicated. Cells were
labeled with Tran[35S]-label for 3 hr before harvesting. PHis6hCUL1
(A) and CDK2HA (B) together with associated proteins were immu-
noprecipitated by anti-Polyoma and anti-HA beads, respectively. The
composition of the protein complexes in the immunoprecipitates was
analyzed by SDSyPAGE followed by autoradiography.
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Human CUL1 Directly Interacts with hSKP1 and SKP2. The
results in Fig. 2 suggest that hCUL1, hSKP1, and SKP2 can
assemble into an SCF-like particle when coexpressed in insect
cells. Because of the strong conservation of SCF components,
however, these interactions might be mediated by other proteins
provided by the host cells (for an example, see ref. 6). To test
whether the observed interactions are direct, we produced GST-
hSKP1, GST-SKP2, and MBP-hCUL1 in bacteria. The GST
fusions (or unfused GST control) were mixed with MBP-hCUL1
or MBP and were recovered by binding to glutathione-Sepharose
beads. Bound proteins were resolved by SDSyPAGE and were
visualized by Coomassie blue staining (Fig. 3). MBP-hCUL1 but
not MBP bound specifically and efficiently to GST-hSKP1 and
GST-SKP2 but not GST. This result demonstrates that hCUL1
can bind to both hSKP1 and SKP2 without the participation of
other proteins.
Human CUL1 Is Functionally Homologous to CDC53 and Can
Form an Active Chimeric SCF Complex with ySKP1 and CDC4.
The above observations indicate that hCUL1, the closest human
homologue of CDC53, can assemble with hSKP1 and the F-box
protein SKP2 into a complex reminiscent of the yeast SCFGRR1
complex. We next tested whether this complex—in the presence
of hCDC34, E1 enzyme, and ubiquitin—was able to ubiquitinate
proteins that either bind to it (Cyclin A; ref. 10), are known to be
degraded in S phase (Cyclin E, E2F-1; refs. 18, 19, 21, and 22), or
have been implicated as substrates of hCDC34 (p27; refs. 16, 17).
These efforts were unsuccessful (data not shown), raising the
question of whether SCFSKP2 complexes possess ubiquitin ligase
activity. Moreover, ubiquitin ligase activity of the analogous yeast
SCFGRR1 complex has not been demonstrated yet and might
require additional unidentified components. However, we were
able to address whether hCUL1 is a functional component of a
ubiquitin ligase complex genetically and biochemically by taking
advantage of the considerable knowledge of this pathway in yeast.
First, we asked whether hCUL1 can complement the cdc53ts
mutation. We introduced hCUL1 and CDC53 under the control
of the GAL1 promoter into a yeast strain carrying a temperature-
sensitive mutation in the CDC53 gene. Individual transformants
were spotted at different dilutions on glucose (noninducing
conditions, data not shown) and galactose (inducing conditions)
media at permissive (24°C) and restrictive (33°C) temperatures
(Fig. 4). Only transformants that expressed wild-type CDC53 or
hCUL1 proteins were able to grow at the restrictive temperature.
However, hCUL1 failed to complement a cdc53 null strain (data
not shown).
The ability of hCUL1 to complement the cdc53ts mutation
implied that hCUL1 can assemble into functional SCF complexes
with yeast proteins. To test this idea, we examined whether
hCUL1 can interact with the budding yeast SCF subunits ySKP1
and CDC4. All three proteins were coexpressed in [35S]-
methionine-radiolabeled insect cells in various combinations, as
indicated in Fig. 5. Human CUL1 specifically coimmunoprecipi-
tated with ySKP1HA (Fig. 5A, lane 2) or PHACDC4yySKP1 (Fig.
5B, lane 4), indicating that it can form a chimeric SCFCDC4
complex with yeast proteins.
Our previous findings (6) identified SCFCDC4 as a functional E3
that required the presence of all three subunits (CDC4, CDC53,
and ySKP1) to catalyze ubiquitination of phosphorylated SIC1 (6,
7). Preceding its ubiquitination, phosphorylated SIC1 is recruited
to SCF CDC4 by binding to the CDC4yySKP1 substrate receptor
(6, 7). Given that hCUL1 and hSKP1 assembled with CDC4 (Fig.
5B), we sought to test whether these hybrid SCF complexes were
able to promote ubiquitination of phosphorylated SIC1. Purified
chimeric SCF complexes were incubated with MBP-SIC1MHis6
and purified ubiquitination components. In the presence of
SCFCDC4 (Fig. 6A, lane 1), MBP-SIC1MHis6 was converted effi-
ciently to high molecular weight forms. Omission of either CDC4,
CDC53, or ySKP1 resulted in no activity (Fig. 6A, lanes 2–4).
Replacement of CDC53PHA with PHis6hCUL1 resulted in an SCF
complex with modest ubiquitination activity that depends on both
CDC4 and ySKP1 (Fig. 6A, lanes 5, 6, and 9). Additionally, an
SCF complex containing both PHis6hCUL1 and hSKP1 along with
PHACDC4 also was able to catalyze ubiquitination of MBP-
SIC1MHis6 (Fig. 6A, lane 10). The conversion of MBP-SIC1MHis6
to high molecular weight forms by hybrid CDC4yhCUL1yhSKP1
FIG. 3. Human CUL1 binds directly to hSKP1 and SKP2. MBP,
MBP-hCUL1, GST, GST-hSKP1, and GST-SKP2 were expressed
individually in and purified from bacteria. Each protein was present in
the binding reactions at 65 mgyml. Proteins (4 mg of each) were loaded
in lanes 1–5, which represents 1y5 of the input for the binding
reactions. Proteins were mixed as indicated (lanes 6–10) and incubated
on ice for 1 hr. GST and GST fusions were collected on glutathione-
Sepharose (GSH-Sepharose) for 1 hr at 4°C, and the beads then were
washed three times with 20 mM Hepes (pH 7.6), 150 mM NaCl, 0.1%
Triton X-100, 5 mM MgCl2, 5 mM EDTA, and 2 mM DTT. Proteins
bound to glutathione-Sepharose were resolved by SDSyPAGE and
were visualized by staining with Coomassie blue. Positions of the
full-length fusion proteins are indicated by the arrows. An '70-kDa
band that copurified with GST-SKP2 from bacteria is marked by an
asterisk.
FIG. 4. hCUL1 complements the cdc53ts mutant phenotype. A
cdc53–2ts mutant strain was transformed with pTS161-CDC53 and
pTS161-hCUL1 plasmids that allow controlled expression of CDC53
and hCUL1 from the galactose-inducible GAL1 promoter. The empty
vector alone was used as a negative control. Serial dilutions 1y10 of the
individual transformants were spotted on synthetic galactose medium
and were incubated for 5 days at restrictive (33°C) and permissive
(24°C) temperatures.
FIG. 5. Human CUL1 can interact with the yeast SCF components
ySKP1 and CDC4. Hi5 insect cells were infected with baculovirus
constructs expressing various proteins as indicated. Cells were labeled
with Tran[35S]-label for 3 hr before harvesting. Yeast SKP1HA (A) and
PHACDC4 (B) together with associated proteins were immunopre-
cipitated by anti-HA and anti-Polyoma beads, respectively. The com-
position of the protein complexes in the immunoprecipitates was
analyzed by SDSyPAGE followed by autoradiography. The asterisk
marks an unidentified contaminant that migrates reproducibly faster
than the authentic hCUL1.
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complexes required both substrate phosphorylation (Fig. 6B, lane
5) and the presence of ubiquitin (Fig. 6B, lane 6). Interestingly,
coexpression of PHACDC4, CDC53PHA, and hSKP1 did not result
in a functional SCF complex (Fig. 6A, lane 7).
CDC53 was shown to interact with yCDC34 (32). Thus, we
presumed that an SCF complex containing hCUL1 would prefer
to use hCDC34 as an E2 as opposed to yCDC34. However,
SCFCDC4 complexes containing PHis6hCUL1 with either
ySKP1His6 or hSKP1 appeared to work much more efficiently with
yCDC34 than with hCDC34 serving as the E2 (Fig. 6C, lanes 3,
4, 7, and 8). Although we do not understand the basis for this
preference, it is possible that there exist additional human
CDC34-like E2s that interact preferentially with hCUL1-
containing complexes. Alternatively, the interaction between an
F-box subunit and an E2 enzyme might also contribute to the
specificity for a particular E2 (38).
Human CUL1 Assembles with Ubiquitination-Promoting Ac-
tivities in Human Cell Extracts. The data presented so far are
consistent with hCUL1 functioning as a component of a ubiquitin
ligase complex in human cells. Because we have failed so far to
detect ubiquitination activity by using recombinant hCUL1y
hSKP1ySKP2 complexes, we sought to develop an assay that
would allow us to identify either substrates or cofactors of a
hCUL1-dependent ubiquitination pathway. PHis6hCUL1 pro-
duced in insect cells in the presence or absence of hSKP1 plus
SKP2 was bound to anti-Polyoma beads and incubated with crude
HeLa S3 lysates to allow binding of other potential SCF compo-
nents, regulators, and substrates. After washing away unbound
proteins, E1, hCDC34, BUb, and an ATP-regenerating system
then were added to the beads. After an incubation, reactions were
fractionated by SDSyPAGE, were transferred to nitrocellulose,
and were blotted with streptavidin-HRP to detect ubiquitin
conjugates. Whereas Phis6hCUL1 or Phis6hCUL1yhSKP1ySKP2
complexes isolated from insect cells exhibited little ubiquitination
activity (Fig. 7A, lane 2 and Fig. 7B, lanes 3 and 4), a high
molecular weight smear characteristic of ubiquitinated proteins
appeared (Fig. 7A, lane 3 and Fig. 7B, lanes 6 and 7) when these
same components were preincubated with HeLa S3 lysate before
the assay. In contrast, no signal was detected when naked
polyoma beads were preincubated with HeLa S3 lysate (Fig. 7A,
lane 1). The appearance of slowly migrating biotinylated proteins
depended on the addition of ubiquitin and ATP-regenerating
system to the reaction (Fig. 7B, lanes 8 and 9), indicating that the
high molecular weight smear was caused by ubiquitination oc-
curring during the in vitro incubation.
DISCUSSION
Multiple homologues of the ySKP1, CDC53, and F-box subunits
of the SCF ubiquitin ligase complex have been identified (10–13)
and implicated in various cellular processes, including kineto-
chore function (33, 34), S-phase progression (10), exit from the
cell cycle (12), transcript elongation, regulation of hypoxia-
inducible genes, and suppression of tumorigenesis (25, 26). Based
on the close homology between hCUL1 and CDC53, we sought
to address whether hCUL1 functions as part of an SCF-like
ubiquitin ligase complex in human cells. A two-hybrid screen to
identify proteins that interact with hCUL1 yielded hSKP1, sug-
gesting that hCUL1 does indeed assemble into SCF-like com-
plexes in human cells. Several other observations reported here
support this hypothesis. First, hCUL1 associates with hSKP1 in
transfected HeLa S3 cells. Second, hCUL1 assembles into com-
plexes with both hSKP1 and the F-box protein SKP2 in vitro.
Third, hCUL1 complements the growth defect of a cdc53ts
FIG. 6. SIC1 is ubiquitinated by chimeric SCF complexes. (A) Hi5
insect cells were infected with various baculoviruses expressing
PHACDC4, CDC53PHA (53), PHis6hCUL1 (C), ySKP1His6 (Y), or
hSKP1 (H) as indicated. At 72 hr post-infection, lysates were prepared
and SCF complexes were affinity purified on an anti-Polyoma matrix,
and eluted complexes were incubated for 2 hr at 25°C with MBP-
SIC1MHis6 in the presence of His6yUBA1 (E1), yCDC34 (E2), purified
CLN2yGST-CDC28HAyCKS1, ubiquitin, and an ATP-regenerating
system. At the end of the incubation, the samples were fractionated by
SDSyPAGE and were immunoblotted with anti-myc antibodies to
detect MBP-SIC1MHis6. Bound antibodies were visualized by ECL. (B)
The indicated SCF complexes were purified from baculovirus-infected
insect cell lysates and were incubated with the full set of ubiquitination
components (lanes 1 and 4) or in the absence of CLN2yGST-
CDC28HAyCKS1 (lanes 2 and 5) or ubiquitin (lanes 3 and 6). (C)
Purified SCF complexes containing CDC53PHA (53), PHis6hCUL1
(CUL1), ySKP1His6 (Y), or hSKP1 (H) subunits were incubated with
ubiquitination components containing either yCDC34 (Y) or hCDC34
(H).
FIG. 7. Human CUL1 associates with ubiquitination activity in
HeLa S3 lysates. (A) Anti-Polyoma beads were incubated in the
presence of PHis6hCUL1, HeLa S3 lysates, or both as indicated, were
washed five times with lysis buffer, and were mixed with the ubiquiti-
nation reaction components (Rxn mix) His6yUBA1, hCDC34, BUb,
and ATP-regeneration system. Incorporation of BUb into proteins
present in the reactions was monitored by probing with streptavidin-
HRP conjugate followed by ECL detection. (B) PHis6hCUL1 alone or
together with hSKP1 and SKP2 was produced in insect cells and was
bound to anti-Polyoma beads that then were washed and incubated at
4°C in the presence or absence of crude HeLa S3 lysates to allow bead
‘‘activation’’. Activated beads then were treated as in A. Dependence
on the presence of ATP and BUb in the reactions was determined by
omitting these components from the reaction mix (lanes 5, 8, and 9,
respectively). The entire reaction mix was omitted in lane 10. Lane 1
contained reaction mix only. P-BUbn designates a ladder of ubiquiti-
nated proteins produced in the reaction.
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mutant. Fourth, hCUL1 and hSKP1 can form chimeric SCF
complexes with CDC4, and these complexes are able to ubiqui-
tinate the SCFCDC4 substrate SIC1 in vitro. Fifth, hCUL1 asso-
ciates with ubiquitination-promoting activity in HeLa S3 cell
lysate. Taken together, these data strongly suggest that hCUL1 is
a subunit of an SCF-like E3 complex in human cells.
What are the candidate substrates for hCUL1-dependent
ubiquitination in human cells? SIC1, CLN2, and FAR1 must be
phosphorylated before they can be ubiquitinated by the budding
yeast SCFyCDC34 pathway (6, 7, 35). The stability of many
mammalian regulatory proteins—including IkB, b-catenin, p27,
Cyclin D, and Cyclin E—is known to be controlled by phosphor-
ylation (16–20, 36, 37). Further work will be required to deter-
mine whether any of these proteins are substrates for human SCF
complexes. SCF-associated Cyclin A might also be a substrate of
the SCFSKP2 pathway. This is less likely, though, because Cyclin
A is thought to be primarily destroyed via the antigen-presenting
cellycyclosome pathway, and both Cyclin A and SKP2 activities
are essential for entry into S phase (10). Instead, the tight
association of Cyclin AyCDK2 with SCF subunits both in vivo and
in vitro might reflect an efficient coupling between substrate
phosphorylation and ubiquitination in transformed cells.
While this manuscript was in preparation, a study that com-
plements our findings was reported by Lisztwan et al. (38). These
authors demonstrated that hCUL1, hSKP1, and SKP2 assemble
into a complex both in unperturbed and transfected human cells.
Moreover, SKP2 also was shown to bind the ubiquitin-
conjugating enzyme hCDC34 in human cells, suggesting that
SKP2 is part of an SCF-like ubiquitin ligase. SKP2 also was shown
to associate with Cyclin AyCDK2, and mutational analysis sug-
gested that Cyclin AyCDK2 binding might regulate SKP2yhSKP1
but not SKP2yhCUL1 interaction in vivo. Our data support these
findings and extend them by establishing that hCUL1 interacts
directly with hSKP1 and SKP2 without the participation of other
eukaryotic proteins, and hCUL1 and hSKP1 can assemble into
active ubiquitin ligase complexes either in insect cells or in HeLa
S3 cell lysates.
Further characterization of the SCF pathway in human cells
will require the identification of functional F-box subunits and
physiological substrates. The ability to stimulate the E3 activity of
insect cell-derived hCUL1 with HeLa S3 cell lysate provides a
strategy for identifying these proteins. Moreover, this assay can be
adapted readily to test whether the related hCUL2-hCUL5
proteins also assemble into ubiquitin ligase complexes in human
cells. Lastly, by converting either the chimeric SCF complex assay
(Fig. 6) or the biotin-ubiquitin-based assay (Fig. 7) to a microtiter
plate format, it should be feasible to screen chemical libraries to
identify compounds that modulate the activities of hSKP1 and
hCUL1. Given its critical role in cell division in budding yeast,
inhibitors of human SCF might be valuable lead compounds for
the development of novel anti-cancer chemotherapeutics.
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